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Binge eating disorder and night eating
syndrome in adults with type 2 diabetes: a
systematic review
Sally Abbott1,2,3, Naomi Dindol1, Abd A. Tahrani1,2,3 and Milan K. Piya4,5*
Abstract
Background: Type 2 diabetes (T2DM) is increasing in prevalence worldwide, and is closely linked to obesity. Binge
Eating Disorder (BED) and Night Eating Syndrome (NES) are eating disorders that are common in obesity, and
may affect the management as well as long term outcomes of T2DM. Therefore, the aim of this review was to
assess the prevalence and associations of BED or NES in adults with T2DM.
Methods: We conducted a systematic review. The databases MEDLINE, CINAHL and AMED were searched for
articles which met the inclusion criteria; including patients > 18 years old, with T2DM, and BED and/or NES. The
reference lists of included studies were also searched. Meta-analysis was not attempted due to the limited number
of studies that measured the outcomes of interest.
Results: A total of 10 studies (2 included NES) were included in this systematic review. The number screened for
BED and NES were 6527 and 1039 participants, respectively. Point prevalence was 1.2–8.0% for BED and 3.8–8.4%
for NES. Patients with T2DM and BED had higher BMI than patients with T2DM without BED in the two studies that
reported BMI. There was no statistically significant difference in HbA1c between patients with and without BED in
the two studies that measured HbA1c.
Conclusions: BED and NES are common in adults with T2DM, and BED is associated with higher BMI in patients
with T2DM. However, only two studies reported important outcomes measures such as BMI and HbA1c in patients
with T2DM. Hence, further well-designed studies are needed to assess the impact of BED and NES in patients with
T2DM. Health Care Professionals should consider the diagnosis of BED and NES in patients with T2DM.
Introduction
There is an increasing prevalence of diabetes worldwide,
with over 400 million people living with Type 2 Diabetes
Mellitus (T2DM), which is expected to rise to over 600
million by 2045 [1].The link between obesity and T2DM
is well documented [2–6]. Obesity prevention and
management is required to reduce the prevalence of
T2DM, but the main aim of managing existing T2DM is
to improve glycaemic control and cardiovascular disease
risk factors to prevent long term micro and macro
vascular complications [6, 7].
Binge Eating Disorder (BED) and Night Eating
Syndrome (NES) are two eating disorders that are more
common in people with obesity [8–10]. Bulimia Nervosa
is another eating disorder that may occur in obesity and
T2DM. Although not discussed in this article, Bulimia
Nervosa has been covered in a previous review paper
which found a prevalence of 0.3% among individuals
with T2DM [11]. BED is characterised by consuming an
objectively large amount of food over a discrete period
of time; accompanied by a sense of loss of control and
distress [12]. BED is prevalent in 1.9% to 2.8% of the
general population [9], and people with BED are at 3–6
times greater risk of having obesity compared to those
without BED [9]. A higher percentage of youths aged
10–17 years with clinical BED have also been found to
have obesity compared to non-overeaters with a BMI
above the 99th centile; 66.7% vs. 37.7%, (p < 0.05) [13].
* Correspondence: m.piya@westernsydney.edu.au
4Macarthur Clinical School, School of Medicine, Western Sydney University,
Campbelltown, NSW, Australia
5Macarthur Diabetes Service, Camden and Campbelltown Hospitals, South
Western Sydney Local Health District, Campbelltown, NSW, Australia
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Abbott et al. Journal of Eating Disorders  (2018) 6:36 
https://doi.org/10.1186/s40337-018-0223-1
NES describes nocturnal hyperphagia, insomnia and
morning anorexia [14], and affects an estimated 1% of
the general population [15], as high as 6–16% in patients
with obesity [16, 17], and 2–20% of bariatric surgery pa-
tients [17].
Diagnosis of BED and NES is based on the DSM-5 cri-
teria [12, 18], updated in 2013. The updated diagnostic
criteria for BED and NES are described in Table 1. The
most notable change was that BED was acknowledged as
a separate diagnosis for the first time, and NES became
listed as a specific disorder under Other Specified Feeding
or Eating Disorder (OSFED). An individual can have a
diagnosis of NES only if the behaviour is not better ex-
plained by another mental health disorder, such as BED.
Therefore, BED and NES cannot coexist. Treatment rates
for BED and NES are low and less than 40% of individuals
with a lifetime diagnosis of BED have been treated [9].
This may be due to a lack of awareness of, or screening
for BED and NES [19].
Previous studies have shown that patients with BED
have higher prevalence of T2DM compared to general
population matched controls, 15.2% vs. 2.2%, (OR 8.8,
95% CI 4.3–17.9) [20]. In addition, having BED increased
the risk of incident T2DM compared to people without
BED (RR 6.5, 95% CI 3.4–12.3) [20]. Similar results were
found by Hudson et al. in which patients with BED were
at increased risk of T2DM compared to those without
BED (HR 1.7, 95% CI 1.1–2.6) despite adjustment for
age, gender and BMI [21].
BED and NES might have a detrimental impact on the
metabolic parameters in patients with T2DM. Increased
severity of binge eating on a scale questionnaire has
been shown to be significantly associated with increased
risk of metabolic complications including raised HbA1C,
blood pressure and BMI [22]. Experimental studies have
shown that one-day of high-fat overfeeding in humans
resulted in significant increases in postprandial glucose
by 17.1%, and reductions in whole-body insulin
Table 1 Diagnostic Criteria
Eating
Disorder
DSM-IV [18] DSM-5 [12]
BED A Recurrent episodes of binge eating. An episode of binge eating
is characterised by both of the following:
1. eating, in a discrete period (e.g. within any 2-h period), an
amount of food that is definitely larger than most people
would eat in a similar period of time under similar
circumstances
2. a sense of lack of control over eating during the episode
No change
B The binge eating episodes are associated with > 3 of the
following:
1. eating much more rapidly than normal
2. eating until feeling uncomfortably full
3. eating large amounts of food when not feeling physically
hungry
4. eating alone because of being embarrassed by how much
one is eating
5. feeling disgusted, depressed or very guilty after overeating
No change
C Marked distress over binge eating is present No change
D The binge eating occurs on average 2 days per week for
6 months
The binge occurs, on average, more than once per week for
3 months
E The binge eating is not associated with the regular use of
inappropriate compensatory behaviours
The binge eating is not associated with recurrent use of
inappropriate compensatory behaviour, such as in bulimia nervosa.
NES NES would have been considered an eating disorder not
otherwise categorised (EDNOS); but not listed as an eating
disorder in its own right
NES is listed as an eating disorder under the other specified feeding or
eating disorder (OSFED) category:
1. Recurrent episodes of night eating, as manifested by eating after
awakening from sleep or by excessive food consumption after the
evening meal
2. There is awareness and recall of eating
3. Night eating causes significant distress and/or impairment in
functioning
4. The disordered pattern of eating is not better explained by binge
eating disorder or another mental disorder, including substance
use, and is not attributable to another medical disorder or to
an effect of medication
5. The night eating is not better explained by external influences
such as changes in the individual’s sleep–wake cycle or by local
social norms
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sensitivity by 28% [23]. On the other hand, prescribed
dietary components for T2DM management can also
precipitate disordered eating, including dietary restraint
and food preoccupation [24, 25]. In particular, very low
calorie diets have been shown to significantly improve
T2DM control and induce diabetes remission in 46% of
patients with recent onset T2DM [26]. Therefore, more
clinicians are advising low or very low calorie diets to
patients who may have undiagnosed BED or NES. Fur-
thermore, sleep deprivation and poor quality of sleep,
which are characteristics of NES, are also risk factors for
T2DM and obesity [27, 28].
Having BED or NES might have implications on the
choice of treatment in patients with T2DM. For ex-
ample, eating disorders might have an impact on the
outcomes of bariatric surgery, while bariatric surgery
might impact BED and NES [29–31].
Hence, we conducted a systematic review to assess the
prevalence of BED and NES in patients with T2DM. We
also assessed the relationships between BED/NES with
BMI and HbA1c in patients with T2DM.
Methodology
Inclusion criteria were studies of adults (> 18 years old),
with known T2DM and reported data on prevalence of
BED or NES. Diagnosis should have been made accord-
ing to DSM-IV or DSM-5 criterion and using validated
questionnaire or interview methods, outlined in Table 2.
Studies based in eating disorder services were excluded,
as these would have a large selection bias.
Literature searches were made using keywords relevant
to the framed question of this review. Literature searches
were performed for studies from inception up to 26th
January 2018. The databases MEDLINE, CINAHL and
AMED were searched using the terms ‘Night Eating’ OR
‘Night Eating Syndrome’ OR ‘Binge Eating’ OR ‘Binge
Eating Disorder’ OR ‘Eating Disorders’ AND ‘Diabetes’,
‘Diabetes Mellitus Type 2’, ‘Type 2 Diabetes’. To ensure
all relevant literature was captured, the reference lists of
the included primary studies were also searched.
The first two authors independently screened the titles
and abstracts of identified studies. Studies meeting the
eligibility criteria were then screened independently by
both authors, using full-texts to determine inclusion.
Any discrepancies were discussed in arbitration until a
consensus was reached.
Results
Study selection
The study selection process is detailed in Fig. 1. A total of 10
studies were identified for inclusion in the systematic review.
These were generated from a search of the databases, which
retrieved a total of 52 citations. Importing the reference lists
of the 10 included studies provided an additional 339 cita-
tions. After adjusting for duplicates, the citations identified in
the literature search totalled 315. Of those, 285 citations were
discarded after screening their titles and abstracts as they did
not meet the inclusion criteria. The full texts of the
remaining 30 citations were then examined in further detail.
After examination of the full-text, 20 citations were
excluded because they did not meet the inclusion
criteria. The reasons for excluding studies are given in
detail in Fig. 1.
Table 2 Screening Methods
Name Outline
Questionnaire Questionnaire on Eating and Weight Patterns
(QEWP, QEWP-R)
A 27-item self-administered questionnaire that focuses on assessing
diagnostic criteria for BED
Eating Disorder Examination Questionnaire
(EDE-Q)
A self-report version of the EDE interview. A 41-item self-reported
questionnaire generating 4 subscales and a global score.
Night Eating Questionnaire (NEQ) A 14-item survey using 0–4 Likert responses to screen for symptoms
of NES.
Items are also used to distinguish NES from sleep-related eating
disorder (SRED) and to confirm that symptoms have been present
for > 3 months. Total NEQ scores may range from 0 to 52.
Interview Eating Disorder Examination (EDE) A semi-structured interview that provides a profile of psychopathology
based 4 four subscales and a global score.
Night Eating Syndrome History and
Inventory
(NESHI)
A semi-structured interview based on the NEQ that assesses the presence
and frequency of night eating symptoms more comprehensively than the
survey alone and allows for diagnosis of NES to be made.
Structured Clinical Interview for DSM-IV
Axis 1
(SCID-I)
A semi-structured interview to determine whether the individual meets
the DSM-IV criteria for eating disorders.
Structured Interview for Anorexic and
Bulimic Syndromes, for Expert Rating
(SIAB, SIAB-EX)
A semi-structured interview to assess for the specific and general
psychopathology of eating disorders designed to establish diagnosis
according to DSM-III-R.
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Study characteristics
The characteristics of included studies [32–41] are
detailed in Table 3.
Binge eating disorder (BED) and T2DM
Point prevalence data of BED diagnosis was obtained
from 6527 participants across 10 studies [32–38, 40, 41].
All studies were cross sectional in design and 5 of these
[32, 34, 36–38] were multi-centre studies. One study
[32] used two methods of diagnosis and reported point
prevalence separately for each. Positive diagnosis accor-
ding to the EDE-Q questionnaire was then corroborated
with the EDE interview. All other studies used
exclusively either questionnaires (QEWP-R n = 2, QEWP
n = 1) or interviews (SCID-1 n = 2, EDE n = 1, SIAB n = 1,
SIAB-EX n = 1) to establish BED diagnosis. Most studies
established diagnosis of BED according to DSM-IV criteria
(n = 7), while two studies used DSM-5.
Apart from one study [27], which excluded partici-
pants taking psychotropic medications, no other studies
reported whether participants were taking medications
known to influence appetite; such as psychotropic, ste-
roid or anti-diabetes medications like Metformin, DPP-4
inhibitors or GLP-1 agonists. Five studies discussed use
of insulin with two studies excluding participants on in-
sulin [36, 40] and in the remaining three studies 30–51%
of study participants were on insulin [37, 38, 41]. One
study [37] specifically reported insulin use among those
with BED (33%) vs. without BED (52%).
Night eating syndrome (NES) and T2DM
Point prevalence data was obtained from 1039 participants
from two studies [32, 39] for NES diagnosis. One study
[32] was a multi-centre study. Both studies were
cross-sectional, undertaken in the USA and both used
NEQ questionnaires to establish NES diagnosis. One used
DSM-5 [39] criteria; while the other used published
clinical characterisation criteria [42], for diagnosis. One of
these studies [32] then used interview to confirm diagno-
sis, using NESHI, and reported prevalence data according
Fig. 1 Flowchart of studies screened and included in the narrative synthesis and meta-analysis
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to the alternative methods of diagnosis. Neither of these
studies [32, 39] reported insulin use or use of medications
that are known to influence appetite.
Prevalence
Prevalence data is shown in Table 3. The overall point
prevalence of BED was 1.2–25.6%. The point prevalence
for NES was 3.8% to 8.4% [42]. Using interviews to cor-
roborate questionnaires in one study [32], led to a lesser
prevalence of diagnosis of both BED (reduced from 5.6
to 1.4%) and NES (reduced from 8.4 to 3.8%).
Differences between patients with T2DM with and
without BED and NES
Body mass index (BMI)
Two studies [33, 36] reported BMI according to absence
or presence of BED diagnosis. Both studies showed that
BMI was higher in patients with vs. without BED but the
difference in the smaller study did not reach statistical
significance as shown in Table 4.
The association between NES diagnosis and BMI was
reported in one study (n = 194, 13 patients with NES)
[39]. There was no significant difference between the
mean BMI of those with (34.0 kg/m2 [SD 8.3]) and with-
out (BMI 35.7 kg/m2 [SD 8.3]) a diagnosis of NES (p =
ns).
Glycaemic control
The same two studies [33, 36] reporting BMI, compared
HbA1c between patients with T2DM with and without
BED; summarised in Table 5. The larger study [36]
showed no difference in HbA1c between patients with
and without BED, and the smaller study [33] showed
higher HbA1c in patients with BED vs. no BED but this
was not statistically significant. It must be noted that in
the larger study that showed no difference, the HbA1c
was well controlled (7.3%) in both patients with and
without BED.
Results from Hood et al. [39] found no statistical dif-
ference in the HbA1c of those with and without NES, al-
though the number of patients with T2DM was small
(8.4% [SD 1.6%] vs. 7.8% [SD 1.6%]; p = ns.
Ethnicity
No data was available on association between ethnicity
and a diagnosis of either BED or NES.
Discussion
This systematic review showed that BED and NES were
common in patients with T2DM, but there was big vari-
ation in the prevalence between the studies, which is
consistent with the findings of a previous review [11].
This large variation between studies may reflect the dif-
ferent populations studied (primary care vs hospital
clinic) as well as the differences in the method used to
diagnose BED. Incorporating interviews to the diagnostic
process resulted in a lower prevalence of BED and NES
compared to questionnaires alone. This difference in the
prevalence of BED based on questionnaires vs. interview
was also noted previously in patients with morbid obes-
ity who were considered for bariatric surgery [43], which
found a lower prevalence of BED using Structured Clin-
ical Interview (SCID) vs. the Questionnaire of Eating
and Weight Patterns-Revised (QEWP-R).
The two studies that reported HbA1c in this system-
atic review showed no statistically significant relation-
ship between BED and HbA1c. One study had very
small numbers included, and the larger study had both
groups with a mean HbA1c of 7.3%, for patients based
in a geographical region in Chile. Findings from this
study may not be generalisable to other T2DM popula-
tions. And regardless of HbA1c, BED may affect gly-
caemic variability due to the consumption of large
amounts of calories over a short period of time and
other behaviours such as prolonged fasting. Hence, the
relationship between BED and glycaemic variability
Table 4 Mean BMI (kg/m2) of Participants With and without BED
Author With BED Without BED Mean Difference
(kg/m2) [95% CI]
Significance
(p)n Mean BMI
(kg/m2)
SD
(kg/m2)
n Mean BMI
(kg/m2)
SD
(kg/m2)
Çelik [18] 8 33.8 6.8 144 30.8 4.9 3.00 [−1.78, 7.78] P = 0.22
Herbozo [21] 31 34.8 7.9 356 31.4 5.5 3.40 [0.56, 6.24] P = 0.02
Table 5 Mean HbA1c (%) of Participants with and without BED
Author With BED Without BED Mean Difference
(%DCCT)
[95%CI]
Significance
(p)n Mean HbA1c (%DCCT) SD
(%DCCT)
n Mean HbA1c (%DCCT) SD
(%DCCT)
Çelik [18] 8 8.7 3.3 144 8.1 2 0.60 [−1.71, 2.91] P = 0.61
Herbozo [21] 31 7.3 1.8 356 7.3 2 0.00 [−0.67, 0.67] P = 1.00
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needs to be examined, particularly given that there is
growing evidence that increased glycaemic variability is
associated with increased vascular disease in patients
with T2DM [43], independent of HbA1c.
This review found higher BMI in patients with BED,
which is consistent with the data from the World Health
Organisation showing a high prevalence of obesity
amongst patients with BED [9]. However, due to the de-
sign of the studies included in our systematic review, it
is difficult to ascertain the direction of the relationship
between BED and obesity in patients with T2DM, par-
ticularly as a bidirectional relationship is biologically
plausible. Hence, further longitudinal studies and RCTs
are needed to examine the relationships between BED
and obesity in patients with T2DM.
Study limitations
More than half of the included studies were conducted at
a single site, reducing the generalisability of the sample.
Overall our systematic review showed that there is very
limited data available to assess the relationships between
BED/NES and diabetes-related outcomes in patients with
T2DM. The two studies that measured diabetes-related
outcomes and the number of patients with BED and NES
included in the analysis were small. Furthermore, all these
studies were cross-sectional. Hence causality and direction
of relationships could not be ascertained. There is also a
lack of data regarding ethnicity, which might play an im-
portant role in the relationship between BED/NES and
T2DM. Hence, future studies need to take the
above-mentioned limitations into account. Moreover, the
use of medications known to affect appetite and thus in-
fluence eating behaviour was seldom reported.
Conclusions
Our findings demonstrate that a considerable proportion
of adults with pre-existing T2DM have clinical BED and
NES. It is therefore important for healthcare professionals
working in the field of T2DM to be vigilant regarding the
possible diagnosis of BED or NES in their patients. Future
studies exploring the impact of BED/NES in the manage-
ment of T2DM and development of long term diabetes
complications are required. The effect of newer
anti-diabetes therapies that reduce appetite, and the in-
creasing use of very low calorie diets and bariatric surgery
in the management of T2DM, make screening and early
diagnosis of these eating disorders even more important.
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